About Rhomboid-related protein 1
Rhomboid-related protein 1 (RHBDL1) is a protein
from Homo sapiens identified by UniProt accession
O75783, 438 residues long.
MolForge cross-references it against 0 known binders and
25 disease associations.
Target properties
| Protein name | Rhomboid-related protein 1 |
| UniProt accession | O75783 |
| Gene | RHBDL1 |
| Organism | Homo sapiens |
| Length | 438 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (25)
Diseases linked to this target (Open Targets).
- platelet count · score 0.06
- isolated asymptomatic elevation of creatine phosphokinase · score 0.05
- pentosuria · score 0.05
- Crigler-Najjar syndrome type 2 · score 0.04
- self reported educational attainment · score 0.04
- transient familial neonatal hyperbilirubinemia · score 0.03
- gluthathione peroxidase deficiency · score 0.03
- hypercholanemia, familial, 2 · score 0.03
- platelet crit · score 0.03
- Rotor syndrome · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-O75783-F1 | alphafold | PREDICTED | 72.57 | — |
Amino-acid sequence (438 residues)
MGRVEDGGTT EELEDWDPGT SALPAPGIKQ GPREQTGTGP LSQKCWEPEP DAPSQPGPAL WSRGRARTQA LAGGSSLQQL DPENTGFIGA DTFTGLVHSH ELPLDPAKLD MLVALAQSNE QGQVCYQELV DLISSKRSSS FKRAIANGQR ALPRDGPLDE PGLGVYKRFV RYVAYEILPC EVDRRWYFYR HRSCPPPVFM ASVTLAQIIV FLCYGARLNK WVLQTYHPEY MKSPLVYHPG HRARAWRFLT YMFMHVGLEQ LGFNALLQLM IGVPLEMVHG LLRISLLYLA GVLAGSLTVS ITDMRAPVVG GSGGVYALCS AHLANVVMNW AGMRCPYKLL RMVLALVCMS SEVGRAVWLR FSPPLPASGP QPSFMAHLAG AVVGVSMGLT ILRSYEERLR DQCGWWVVLL AYGTFLLFAV FWNVFAYDLL GAHIPPPP
Explore Rhomboid-related protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets